Hematopoietic Progenitors Cell Transplantation

HPCT, or bone marrow transplantation, involves eliminating the patient's damaged marrow and replacing it with haematopoietic progenitor cells.


Among the therapeutic options available for haematological diseases, haematopoietic progenitor cell transplantation (HPCT) can be thought of as the main technique in the treatment of large numbers of patients suffering from leukaemia, lymphoma and myeloma. 

The HM Hospitales Group is aware of this, and offers a Haematopoietic Progenitor Cell Transplantation Unit at Hospital Universitario HM Sanchinarro and at Hospital Universitario HM Montepríncipe.


Structure of the Bone Marrow Transplantation Medical Team

The medical team that's directly involved in the HM Hospitales HPCT program includes six specialists in Haematology and Haemotherapy and two specialist doctors in Paediatric Haematology and Oncology.

Program Director

Prof. Dr Jaime Pérez de Oteyza

Haematology Service

  • Dr Alfons Serrano
  • Dr Mª Luisa Bengochea
  • Dr Esther Rodrigo
  • Dr Mercedes Gasior (tissue establishment)

Pediatrics Service

  • Prof. Dr Blanca López Ibor
  • Dr Marta Villa
  • Associate: Dr Miguel Ángel Díaz

Nursing staff

  • Nursing supervisor: Pilar Monte
  • The nursing staff is made up of nurses with special training in caring for patients with blood cancer, and in performing therapeutic apheresis procedures.

trasplants hematopoietic

Centers that offer Haematopoietic Progenitor Cell Transplantation

HM Sanchinarro

Calle Oña nº 10 28050 Madrid

HM Montepríncipe

Avenida de Montepríncipe, nº25 28660 Boadilla del Monte, Madrid

Subir arriba (en-gb)